. Author manuscript; available in PMC: 2016 Aug 23.

Published in final edited form as: Leukemia. 2015 Jul 23;30(1):190–199. doi: 10.1038/leu.2015.194

Table 1.

Characteristics of AML specimens

Patient	Specimen	Diagnosis	Specimen site	Time of collection	Cytogenetics	FLT3 status
1	AML-CK1	AML	Bone marrow	Diagnosis	46,XX,dup(2)(q21q33), t(8;16)(p11;p13), psu dic(22;1)(p11;p11)[10]/46,XX,dup(1)(q32q42), t(8;16),psu dic(9;1)(q34;p11) [4]/46,XX,t(8;16),psu dic(19;1) (p13;p11)[4]/46,XX[2]	WT
2	AML-CK2	AML	Bone marrow	Diagnosis	46,XY,-2,der(5)t(2;5)(q3?1;q2?5), inv(11)(q21q23),add(15)(p11), del(20)(q12),+mar[19]/46, XY[1]	WT
3	AML-CN	AML-M4	Bone marrow	Relapse	46, XX	FLT3-ITD

Abbreviations: AML, acute myeloid leukemia; WT, wild type.